Table 1 The association between CRI and the risk factors (univariate analysis)
From: Central venous catheter related infections: Risk factors and the effect of glycopeptide antibiotics
Risk groups | Total | CRI | RR* | (%95 CI**) | p value | ||
|---|---|---|---|---|---|---|---|
n | (%) | n | (%) | ||||
Unit | |||||||
Surgical ICU | 92 | (30.7) | 20 | (21.7) | 1.53 | (0.90–2.60) | 0.12 |
Neurosurgical ICU | 32 | (10.7) | 5 | (15.6) | 1.10 | (0.46–2.66) | 0.79 |
Medical ICU | 176 | (58.6) | 25 | (14.2) | 1.00 | ||
Gender | |||||||
Male | 148 | (49.3) | 25 | (16.9) | 1.03 | (0.62–1.70) | 0.92 |
Female | 152 | (50.7) | 25 | (16.4) | 1.00 | ||
CVC insertion site | |||||||
Jugular vein | 132 | (44) | 30 | (22.7) | 1.91 | (1.14–3.20) | 0.01 |
Subclavian vein | 168 | (56) | 20 | (11.9) | 1.00 | ||
Repeated catheterization | |||||||
Subsequent catheters | 197 | (65.7) | 34 | (17.2) | 1.13 | (0.54–2.72) | 0.87 |
First catheter inserted | 103 | (34.3) | 16 | (15.5) | 1.00 | ||
Total parenteral nutrition | |||||||
No | 272 | (90.7) | 46 | (16.9) | 1.18 | (0.46–3.05) | 0.99 |
Yes | 28 | (9.3) | 4 | (14.3) | 1.00 | ||
Primary diagnosis | |||||||
Cardiorespiratory failure | 81 | (27) | 14 | (19.4) | 0.97 | (0.51–1.87) | 0.93 |
Trauma | 72 | (24) | 9 | (12.5) | 0.63 | (0.29–1.34) | 0.22 |
Postsurgical | 72 | (24) | 12 | (14.8) | 0.74 | (0.37–1.48) | 0.39 |
Others | 75 | (25) | 15 | (20.0) | 1.00 | ||
Duration of catheterization | |||||||
≥ 8 day | 99 | (33) | 24 | (24.2) | 1.87 | (1.14–3.09) | 0.01 |
≤ 7 day | 201 | (67) | 26 | (12.9) | 1.00 | ||
Glycopeptide usage | |||||||
No | 187 | (62.4) | 45 | (24.0) | 4.45 | (1.46–3.14) | 0.001 |
Yes | 113 | (37.6) | 5 | (4.4) | 1.00 | ||